Encysive Wins Dismissal Of Securities Suit

Law360, New York (September 18, 2007, 12:00 AM EDT) -- A federal judge has dismissed a proposed class action lawsuit that accused Encysive Pharmaceuticals Inc. of misleading investors about the prospects for its pulmonary arterial hypertension treatment Thelin.

Judge Nancy F. Atlas of the U.S. District Court for the Southern District of Texas ruled Tuesday that the plaintiffs had failed to state a claim upon which relief could be granted and that they did not raise an issue of scienter.

In her opinion, Atlas also cited the Supreme Court's Bell Atlantic v. Twombly decision, which “made...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.